Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception.
Journal: BMC cancer
Published: June 20, 2025
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment.
Journal: JAMA oncology
Published: November 07, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: April 26, 2024
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
Journal: AJR. American journal of roentgenology
Published: September 20, 2023
Screening for Prostate Cancer. Reply.
Journal: The New England journal of medicine
Published: July 05, 2023
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
Journal: AJR. American journal of roentgenology
Published: July 05, 2023
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease.
Journal: Cancers
Published: October 29, 2021
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 17, 2021
Last Updated: 09/26/2026